NuVasive Announces Conference Call and Webcast of Third Quarter 2020 Results

Rhea-AI Summary

NuVasive, Inc. (NASDAQ: NUVA), a leader in spine technology, will release its third quarter 2020 earnings results on October 29, 2020, after market close. A conference call to discuss financial performance will occur the same day at 4:30 p.m. ET. Domestic and international callers can dial 1-877-407-9039 and 1-201-689-8470, respectively. A live webcast will be available on the company's Investor Relations page, and replays will be accessible until November 5, 2020, for telephone and until November 29, 2020 for the webcast.

Positive

• Leader in spine technology with over $1 billion in net sales.
• Conference call scheduled for October 29, 2020, to discuss financial performance.

Negative

• None.

SAN DIEGO, Oct. 19, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2020 earnings results on Thursday, October 29, 2020 after the close of the market.

NuVasive will hold a conference call on Thursday, October 29, 2020, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the third quarter 2020. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers. A live webcast of the conference call will be available online from the Investor Relations page of the Company's website at www.nuvasive.com.

After the live webcast, the call will remain available on NuVasive's website through November 29, 2020. In addition, a telephone replay of the call will be available until November 5, 2020. The replay dial-in numbers are 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers. Please use pin number: 13708396.

About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With more than $1 billion in net sales, NuVasive has approximately 2,800 employees and operates in more than 50 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com.

Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, but are not limited to, the risk that NuVasive's net sales or earnings projections may turn out to be inaccurate because of the preliminary nature of the forecasts; the risk of further adjustment to financial results or future financial expectations; unanticipated difficulty in selling products, generating net sales or producing expected profitability; and those other risks and uncertainties more fully described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

View original content to download multimedia:http://www.prnewswire.com/news-releases/nuvasive-announces-conference-call-and-webcast-of-third-quarter-2020-results-301155031.html

SOURCE NuVasive, Inc.

FAQ

When will NuVasive release its third quarter 2020 earnings results?

NuVasive will release its third quarter 2020 earnings results on October 29, 2020, after market close.

What time is the conference call for NuVasive's third quarter results?

The conference call for NuVasive's third quarter results is scheduled for October 29, 2020, at 4:30 p.m. ET.

How can I access NuVasive's earnings call replay?

The earnings call replay for NuVasive will be available until November 5, 2020, by dialing 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers.

Where can I find the live webcast of NuVasive's conference call?

The live webcast of NuVasive's conference call will be available on the company's Investor Relations page at www.nuvasive.com.

What is NuVasive's business focus?

NuVasive focuses on transforming spine surgery with minimally disruptive and procedurally integrated solutions.